Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Encompass Health Corporation due to allegations of materially misleading business information [1] Group 1: Investigation and Allegations - The investigation is prompted by an article from The New York Times highlighting serious incidents of patient harm and below-average performance on key safety measures at Encompass Health's rehab hospitals [3] - Following the publication of the article, Encompass Health's stock price dropped by 10.3% on July 15, 2025 [3] Group 2: Class Action Details - Investors who purchased Encompass Health securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Luminar Technologies, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][3]. Group 1: Class Action Details - Investors who purchased Luminar securities between March 20, 2025, and May 14, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 22, 2025 [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that Luminar's executives made false and misleading statements, including undisclosed conduct by CEO Austin Russell that could lead to his removal, adversely affecting the company's business and financial guidance [5]. - The negative public perception and news related to Russell could harm Luminar's brand relationships and competitive standing in the industry [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Luminar Technologies, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on September 22, 2025 [1] Group 1: Class Action Details - Investors who purchased Luminar securities between March 20, 2025, and May 14, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 22, 2025 [3] - Investors are encouraged to select qualified counsel with a successful track record in securities class actions [4] Group 2: Case Allegations - The lawsuit alleges that Luminar's executives made false and misleading statements and failed to disclose critical information regarding CEO Austin Russell's undisclosed conduct, which could lead to his removal [5] - The potential loss of Russell could adversely affect Luminar's business operations, including competition, R&D management, and customer relationships [5] - The lawsuit claims that Luminar had no reasonable basis for its financial guidance, and the public statements made by the defendants were materially false and misleading [5]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Lockheed Martin securities between January 23, 2024, and July 21, 2025, of the September 26, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Lockheed Martin securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 26, 2025 [3]. - The lawsuit alleges that Lockheed Martin made false and misleading statements regarding its internal controls and ability to meet contract commitments, which led to significant investor losses when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [4].

Company Overview - TOP Financial Group Limited is a fast-growing online brokerage firm based in Hong Kong, specializing in trading local and foreign equities, futures, options products, and other financial services [1][3] - The company has relocated its headquarters to Singapore, which is recognized as a major financial center with stable political policies, economic growth, and a low tax rate [2] Strategic Expansion - The relocation to Singapore is part of the company's strategic expansion plan to explore new business opportunities in Southeast Asia [2] - TOP Financial Pte Ltd., a subsidiary of the company, obtained a capital market services (CMS) license from the Monetary Authority of Singapore in June 2025, enhancing product diversification and investor flexibility [2][4] Services Offered - The company provides a range of diversified services through its operating subsidiaries, including online brokerage platforms, asset and funds management, trading solutions, money lending, trust services, and investor relations [3][4] - The operating subsidiaries are licensed with the Securities and Futures Commission of Hong Kong to conduct various regulated activities, including dealing in securities and futures contracts [4] Recent Acquisitions - TOP Financial Group has completed the acquisition of an Australia licensed company, TOP 500 Sec Pty Ltd, which will enable it to provide dealing services in derivatives and foreign exchange contracts [4] - The company has also acquired Zhong Yang Financial Services Limited, which will offer investor relations and public relations services, and is in the process of acquiring a TCSP license in Hong Kong [4]

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased PubMatic, Inc. securities between February 27, 2025, and August 11, 2025, due to alleged misleading statements by the company regarding its business operations and revenue impacts from a significant demand side platform buyer [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that PubMatic made false and misleading statements about its business, failing to disclose a shift of clients from a top demand side platform buyer to a new platform, which resulted in reduced ad spend and revenue [5]. - Investors who purchased PubMatic securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Investors interested in joining the class action can do so by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by October 20, 2025, to represent the class in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Alto Neuroscience, Inc. during the IPO and the subsequent class period about the upcoming lead plaintiff deadline for a class action lawsuit [1][5]. Group 1: Class Action Details - Investors who purchased Alto securities may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 19, 2025 [3]. - The lawsuit alleges that defendants made materially false and misleading statements regarding Alto's business and prospects, particularly concerning the effectiveness of ALTO-100 in treating major depressive disorder [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Novo Nordisk A/S securities between May 7, 2025, and July 28, 2025, of the September 30, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Novo Nordisk securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by September 30, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that defendants made misleading statements about Novo Nordisk's growth potential while concealing material adverse facts [4] Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been recognized for its performance in securities class action settlements [3] Group 3: Case Allegations - The lawsuit claims that Novo Nordisk overstated its growth potential and the likelihood of patients switching to its branded alternatives, leading to investor damages when the true information became public [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fiserv, Inc. common stock between July 24, 2024, and July 22, 2025, of the September 22, 2025, lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Fiserv common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by September 22, 2025 [2] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] Group 2: Allegations Against Fiserv - The lawsuit alleges that Fiserv made false and misleading statements regarding its Clover platform, which was forced upon Payeezy merchants due to issues with the older Payeezy platform [4] - It is claimed that Clover's revenue growth and gross payment volume (GPV) were artificially inflated by these forced conversions, masking a slowdown in new merchant business [4] - The lawsuit further states that many former Payeezy merchants switched to competitors due to Clover's high pricing and compatibility issues, leading to a significant slowdown in Clover's GPV growth and unsustainable revenue growth [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Flywire Corporation securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased Flywire securities between February 28, 2024, and February 25, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 23, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that throughout the Class Period, Flywire's defendants made false and misleading statements regarding the sustainability of the company's revenue growth and the impact of permit and visa-related restrictions on its business [5]. - The lawsuit claims that these misleading statements resulted in investor damages when the true details about Flywire's business performance became public [5].